Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial. [electronic resource]
Producer: 20181004Description: e261-e269 p. digitalISSN:- 2352-3026
- Aged
- Aged, 80 and over
- Antigens, CD20
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Rituximab -- administration & dosage
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.